Redeye initiates coverage of BiBBInstruments, a medtech company developing the EndoDrill
biopsy platform. Following several years of product development and regulatory work,
EndoDrill GI is now entering commercialisation in the US and Europe. While still at an early
stage, the coming years should provide a much clearer picture of the commercial potential
of EndoDrill GI and could reveal further long-term value in the broader platform.

Link to the analysis